<DOC>
	<DOCNO>NCT01176617</DOCNO>
	<brief_summary>The purpose study determine continuous monitoring use implantable loop recorder ( ie . device place underneath skin chest monitor heart rate rhythm ) year long period atrial fibrillation ablation may superior current conventional monitoring strategy use u determination atrial fibrillation recurrence ( ie . return abnormal heart rhythm ) and/or arrythmia burden ( ie . long abnormal rhythm continue often rhythm occurs ) . Some data suggest continuous monitoring long period may better identify recurrence atrial fibrillation ablation thus assist overall management . The device use study Reveal XT , , currently FDA approve monitor variety cardiac rhythm disorder include atrial fibrillation .</brief_summary>
	<brief_title>Assessing Arrhythmias After Ablation Using Implantable Recorders</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Greater 18 year Undergoing ablation atrial fibrillation University Pennsylvania Patients already implant device , include pacemaker , implantable cardiac defibrillator cardiac resynchronization device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>A-Fib</keyword>
	<keyword>AF</keyword>
	<keyword>Persistent</keyword>
	<keyword>Permanent</keyword>
	<keyword>Pulmonary Vein isolation</keyword>
	<keyword>Ablation</keyword>
</DOC>